Loading cancer entity…
Loading cancer entity…
Clinical trials
5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05684692 | Screening Trial for Pain Relief in Schwannomatosis (STARFISH) | recruiting | Phase 2 | 40 | Massachusetts General HospitalOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT03406208 | Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing | completed | N/A | 228 | Massachusetts General HospitalOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT04163419 | Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis | unknown | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT01885767 | Neurofibromatosis (NF) Registry Portal | recruiting | — | 20,000 | The Children's Tumor FoundationOTHER | 1 |
Data updated 22 days agoSource updated Jul 24, 2026source: clinicaltrials
| Aug 30, 2023 |
| clinicaltrials |
| NCT02298270 | Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype | completed | N/A | 65 | Massachusetts General HospitalOTHER | 1 | Jun 23, 2016 | clinicaltrials |